1. 330. RANDOMIZED PHASE II STUDY OF DOCETAXEL VERSUS PACLITAXEL IN PATIENTS WITH ESOPHAGEAL SCC REFRACTORY TO FLUOROPYRIMIDINE- AND PLATINUM-BASED CHEMOTHERAPY: OGSG1201. (24th September 2022) Authors: Matsuyama, Jin; Yamamoto, Sachiko; Kii, Takayuki; Hara, Hiroki; Kawabata, Ryohei; Kawada, Junji; Takeno, Atsushi; Ueda, Shugo; Kawakami, Hisato; Okita, Yoshihiro; Endo, Shunji; Kimura, Yutaka; Yanagihara, Kazuhiro; Okuno, Tatsuya; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fluoropyrimidine-induced intestinal mucosal injury is associated with the severity of chemotherapy-related diarrhea. (1st February 2019) Authors: Ota, Kazuhiro; Takeuchi, Toshihisa; Kojima, Yuichi; Harada, Satoshi; Ozaki, Haruhiko; Sugawara, Noriaki; Hirata, Yuki; Yamaguchi, Toshifumi; Terazawa, Tetsuji; Kakimoto, Kazuki; Kii, Takayuki; Goto, Masahiro; Higuchi, Kazuhide Journal: Scandinavian journal of gastroenterology Issue: Volume 54:Number 2(2019) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003). Issue 1 (28th November 2020) Authors: Sugimura, Keijiro; Yamasaki, Makoto; Yasuda, Takushi; Yano, Masahiko; Hirao, Motohiro; Fujitani, Kazumasa; Kimura, Yutaka; Miyata, Hiroshi; Motoori, Masaaki; Takeno, Atsushi; Shiraishi, Osamu; Makino, Tomoki; Kii, Takayuki; Tanaka, Koji; Satoh, Taro; Mori, Masaki; Doki, Yuichiro Journal: Annals of gastroenterological surgery Issue: Volume 5:Issue 1(2021) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003). Issue 1 (28th November 2020) Authors: Sugimura, Keijiro; Yamasaki, Makoto; Yasuda, Takushi; Yano, Masahiko; Hirao, Motohiro; Fujitani, Kazumasa; Kimura, Yutaka; Miyata, Hiroshi; Motoori, Masaaki; Takeno, Atsushi; Shiraishi, Osamu; Makino, Tomoki; Kii, Takayuki; Tanaka, Koji; Satoh, Taro; Mori, Masaki; Doki, Yuichiro Journal: Annals of gastroenterological surgery Issue: Volume 5:Issue 1(2021) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I/II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807). Issue 9 (September 2014) Authors: Hironaka, Shuichi; Tsubosa, Yasuhiro; Mizusawa, Junki; Kii, Takayuki; Kato, Ken; Tsushima, Takahiro; Chin, Keisho; Tomori, Akihisa; Okuno, Tatsuya; Taniki, Toshikatsu; Ura, Takashi; Matsushita, Hisayuki; Kojima, Takashi; Doki, Yuichiro; Kusaba, Hitoshi; Fujitani, Kazumasa; Taira, Koichi; Seki, Sh... Journal: Cancer science Issue: Volume 105:Issue 9(2014:Sep.) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study). (3rd August 2020) Authors: Satake, Hironaga; Kato, Takeshi; Oba, Koji; Kotaka, Masahito; Kagawa, Yoshinori; Yasui, Hisateru; Nakamura, Masato; Watanabe, Takanori; Matsumoto, Toshihiko; Kii, Takayuki; Terazawa, Tetsuji; Makiyama, Akitaka; Takano, Nao; Yokota, Mitsuru; Okita, Yoshihiro; Matoba, Koreatsu; Hasegawa, Hiroko; Ts... Journal: Oncologist Issue: Volume 25:Number 12(2020) Page Start: e1855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PS02.162: THREE-YEAR OVERALL SURVIVAL UPDATE FROM PHASE II STUDY OF CHEMOSELECTION WITH DCF AND SUBSEQUENT CONVERSION SURGERY FOR LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL CANCER. (14th September 2018) Authors: Yokota, Tomoya; Kato, Ken; Hamamoto, Yasuo; Tsubosa, Yasuhiro; Ogawa, Hirofumi; Ito, Yoshinori; Hara, Hiroki; Ura, Takashi; Kojima, Takashi; Chin, Keisho; Hironaka, Shuichi; Kii, Takayuki; Kojima, Yasushi; Akutsu, Yasunori; Matsushita, Hisayuki; Kawakami, Kentaro; Mori, Keita; Nagai, Yushi; Asami... Journal: Diseases of the esophagus Issue: Volume 31(2018)Supplement 1 Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201. (September 2021) Authors: Yamamoto, Sachiko; Kawakami, Hisato; Kii, Takayuki; Hara, Hiroki; Kawabata, Ryohei; Kawada, Junji; Takeno, Atsushi; Matsuyama, Jin; Ueda, Shugo; Okita, Yoshihiro; Endo, Shunji; Kimura, Yutaka; Yanagihara, Kazuhiro; Okuno, Tatsuya; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗